polychemotherapy, raiotheraoy

2 trials

Sponsors

Japan Clinical Oncology Group(JCOG)

Conditions

previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)

Phase 2

Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)

Active, not recruitingJPRN-C000000068

Japan Clinical Oncology Group(JCOG)previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)

Start: 1998-02-01Target: 108Updated: 2026-06-29

Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)

Active, not recruitingJPRN-C000000092

Japan Clinical Oncology Group(JCOG)previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)

Start: 1993-12-01Target: 108Updated: 2026-06-29